Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for somatostatin receptor 2 (compound)
Most Correlated Studies
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
Most Relevant Literature
- Octreotide inhibits secretion of IGF-1 from orbital fibroblasts in patients with thyroid-associated …
- The role of brain somatostatin receptor 2 in the regulation of feeding and drinking behavior.
- Overexpression of somatostatin receptor type 2 in neuroendocrine tumors for improved Ga68-DOTATATE i…
- Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung c…
- Low beta-arrestin expression correlates with the responsiveness to long-term somatostatin analog tre…
Most Relevant Clinical Trials
- Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine T…
- PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Ce…
- Combined Beta- Plus Auger Electron Therapy Using a Novel Somatostatin Receptor Subtype 2 Antagonist …
- Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Com…
- A Post Marketing Surveillance on Lutathera® in Patients With Somatostatin Receptor Positive Gastroen…
